Are you an innovative company seeking a reliable CDMO partner to help move your drug substance program to its next phase of success? Look no further.
The drug development and manufacturing process can be daunting because there’s no perfect guide that demonstrates the step-by-step route of getting your product to the market. Resilience is here to help identify the building blocks – the framework, scale-up, and manufacturing – to push your program to its next milestone.
Focused on drug substance development and manufacturing, watch this on-demand webinar featuring insights from Evan Pasenello, Head of Commercial Services, to learn how Resilience partners with companies to advance their programs by integrating customized manufacturing solutions at key stages. Evan will detail our capabilities, with a special focus on our bioreactor capacity, decades of combined manufacturing experience, and showcase our three leading drug substance facilities in North America.
This presentation was originally given at the Outsourced Pharma Capacity Update — Drug Substance on October 22, 2024. Don’t miss the chance to see how Resilience can support your company’s growth and success. Register now to access the recording.